PCN52 HEALTH CARE COSTS ASSOCIATED WITH MULTIKINASE INHIBITORS (MKIS) FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN A CLINICAL PRACTICE SETTING IN ITALY
Abstract
Authors
C Paglino C Porta C Canipari L Antrs K Chen S Whittemore A Luka P Ramamurthy MP Neary MS Duh